Efficacy of oral vancomycin in primary prevention of Clostridium Difficile infection in elderly patients treated with systemic antibiotic therapy

被引：12
作者：
Papic, Neven [1 ]
Maric, Lorna Stemberger [1 ,2 ]
Vince, Adriana [1 ,3 ]
机构：
[1] Univ Hosp Infect Dis, Zagreb, Croatia
[2] Univ Zagreb, Sch Dent Med, Zagreb, Croatia
[3] Univ Zagreb, Sch Med, Zagreb, Croatia
来源：
INFECTIOUS DISEASES | 2018年 / 50卷 / 06期
关键词：
RESISTANT ENTEROCOCCI; METRONIDAZOLE; EPIDEMIOLOGY; DISEASE; ADULTS;
D O I：
10.1080/23744235.2018.1425551
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：483 / 486
页数：4
相关论文
共 50 条
  • [21] Therapy for Clostridium difficile infection - any news beyond Metronidazole and Vancomycin?
    Manthey, C. F.
    Eckmann, L.
    Fuhrmann, V.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (11) : 1239 - 1250
  • [22] Clinical outcomes of fidaxomicin vs oral vancomycin in recurrent Clostridium difficile infection
    Tieu, Jennifer D.
    Williams, Riley J., II
    Skrepnek, Grant H.
    Gentry, Chris A.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019, 44 (02) : 220 - 228
  • [23] Resolution of Clostridium difficile-Associated Diarrhea in Patients With Cancer Treated With Fidaxomicin or Vancomycin
    Cornely, Oliver A.
    Miller, Mark A.
    Fantin, Bruno
    Mullane, Kathleen
    Kean, Yin
    Gorbach, Sherwood
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (19) : 2493 - +
  • [24] Fidaxomicin Therapy in Critically Ill Patients with Clostridium difficile Infection
    Penziner, Samuel
    Dubrovskaya, Yanina
    Press, Robert
    Safdar, Amar
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (03) : 1781 - 1786
  • [25] Appropriateness of empiric therapy in patients with suspected Clostridium difficile infection
    Saade, Elie
    Deshpande, Abhishek
    Kundrapu, Sirisha
    Sunkesula, Venkata C. K.
    Guerrero, Dubert M.
    Jury, Lucy A.
    Donskey, Curtis J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (08) : 985 - 988
  • [26] A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies
    Parmar, Sapna R.
    Bhatt, Valkal
    Yang, Jie
    Zhang, Qiao
    Schuster, Michael
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2014, 20 (03) : 172 - 182
  • [27] Evaluation of the effectiveness and safety of oral vancomycin versus placebo in the prevention of recurrence of Clostridioides difficile infection in patients under systemic antibiotic therapy: a phase III, randomised, double-blind clinical trial
    San-Juan, Rafael
    Origuen, Julia
    Campion, Karen
    Fernandez-Ruiz, Mario
    Diaz-Pollan, Beatriz
    Callejas-Diaz, Alejandro
    Candela, Giancarlo
    Angeles Orellana, Maria
    Lora, David
    Llorente Munoz, Irene
    Teresa Garcia, Maria
    Martinez-Una, Maite
    Miguel Ferrari, Jose
    Aguado, Jose M.
    BMJ OPEN, 2023, 13 (09):
  • [28] Loss of Microbiota-Mediated Colonization Resistance to Clostridium difficile Infection With Oral Vancomycin Compared With Metronidazole
    Lewis, Brittany B.
    Buffie, Charlie G.
    Carter, Rebecca A.
    Leiner, Ingrid
    Toussaint, Nora C.
    Miller, Liza C.
    Gobourne, Asia
    Ling, Lilan
    Pamer, Eric G.
    JOURNAL OF INFECTIOUS DISEASES, 2015, 212 (10) : 1656 - 1665
  • [29] Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery
    Bateman, Brian T.
    Rassen, Jeremy A.
    Schneeweiss, Sebastian
    Bykov, Katsiaryna
    Franklin, Jessica Myers
    Gagne, Joshua J.
    Polinski, Jennifer M.
    Liu, Jun
    Kulik, Alexander
    Fischer, Michael A.
    Choudhry, Niteesh K.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 146 (02) : 472 - 478
  • [30] Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence
    Gerding, Dale N.
    Kelly, Ciaran P.
    Rahav, Galia
    Lee, Christine
    Dubberke, Erik R.
    Kumar, Princy N.
    Yacyshyn, Bruce
    Kao, Dina
    Eves, Karen
    Ellison, Misoo C.
    Hanson, Mary E.
    Guris, Dalya
    Dorr, Mary Beth
    CLINICAL INFECTIOUS DISEASES, 2018, 67 (05) : 649 - 656
12345